Fused pancreatic cancer organoid system captures tumor heterogeneity and drug resistance

Precision immunology therapies developed by the company are anticipated to offer significant advantages over existing treatments. Credit: PeopleImages.com – Yuri A / Shutterstock. Precision immunology

Share this article DF1001 is being evaluated in adult patients for the treatment of advanced solid HER-2 positive tumours. Credit: Ground Picture / Shutterstock.com. Dragonfly

Pe­ter Marks, the FDA of­fi­cial who over­sees gene ther­a­pies, is again ad­vo­cat­ing for the use of ac­cel­er­at­ed ap­provals for gene ther­a­pies that treat rare dis­eases.